ISSN (Print):
ISSN (Online):

Current Drug Targets - Immune, Endocrine & Metabolic Disorders

(Continued as Endocrine, Metabolic & Immune Disorders - Drug Targets)

Volume 5 , Issues 4, 2005

Topic(s) Covered

1 Topic(s)


Aims & Scope

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders. Original articles related to Immune Disorders and Drug Targeting are also considered for publication.

Abstracted & Indexed in:

Special Offers

"EMID-DT is a prestigious journal with a multidisciplinary coverage. Its aim is to provide cutting- edge information to readers working in different field of research ranging from immune endocrine to metabolic disorders."

Chris Galanos
Max Planck Institude, Germany

© 2024 Bentham Science Publishers | Privacy Policy